1. Home
  2. RGNX vs USCB Comparison

RGNX vs USCB Comparison

Compare RGNX & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.26

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Logo USCB Financial Holdings Inc.

USCB

USCB Financial Holdings Inc.

N/A

Current Price

$19.67

Market Cap

418.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
RGNX
USCB
Founded
2008
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
418.1M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
RGNX
USCB
Price
$7.26
$19.67
Analyst Decision
Strong Buy
Buy
Analyst Count
11
5
Target Price
$21.40
★ $23.25
AVG Volume (30 Days)
★ 1.1M
90.4K
Earning Date
11-05-2026
10-22-2026
Dividend Yield
N/A
★ 2.54%
EPS Growth
★ 18.08
7.26
EPS
N/A
★ 1.51
Revenue
★ $10,393,000.00
N/A
Revenue This Year
N/A
$20.71
Revenue Next Year
$24.01
$7.63
P/E Ratio
★ N/A
$13.02
Revenue Growth
★ 126.48
N/A
52 Week Low
$5.46
$17.49
52 Week High
$16.19
$23.89

Technical Indicators

Market Signals
Indicator
RGNX
USCB
Relative Strength Index (RSI) 44.73 34.08
Support Level $6.79 $19.15
Resistance Level $7.32 $20.10
Average True Range (ATR) 0.59 0.49
MACD -0.03 0.05
Stochastic Oscillator 15.40 7.96

Price Performance

Historical Comparison
RGNX
USCB

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.

Share on Social Networks: